1. Home
  2. RNA vs MED Comparison

RNA vs MED Comparison

Compare RNA & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avidity Biosciences Inc.

RNA

Avidity Biosciences Inc.

SELL

Current Price

$8.28

Market Cap

141.3M

Sector

Health Care

ML Signal

SELL

Logo MEDIFAST INC

MED

MEDIFAST INC

HOLD

Current Price

$12.74

Market Cap

133.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNA
MED
Founded
2025
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
141.3M
133.7M
IPO Year
2025
1996

Fundamental Metrics

Financial Performance
Metric
RNA
MED
Price
$8.28
$12.74
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $23.00
N/A
AVG Volume (30 Days)
★ 205.4K
107.1K
Earning Date
08-13-2026
10-26-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $934,842,000.00
Revenue This Year
$88.07
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.49
$9.22
52 Week High
$73.06
$13.45

Technical Indicators

Market Signals
Indicator
RNA
MED
Relative Strength Index (RSI) 39.37 56.36
Support Level $7.56 $11.73
Resistance Level $8.50 $12.21
Average True Range (ATR) 0.35 0.38
MACD 0.17 0.04
Stochastic Oscillator 54.46 36.21

Price Performance

Historical Comparison
RNA
MED

About RNA Avidity Biosciences Inc.

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

About MED MEDIFAST INC

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

Share on Social Networks: